Some former executives at Insys Therapeutics have been charged in a kickback scheme that involved bribing clinicians to unnecessarily prescribe pain medications.
The U.S. Justice Department last week arrested six former executives at the Phoenix-based pharmaceutical company. They are accused of bribing practitioners to prescribe a fentanyl-based painkiller called Subsys. The cancer drug was allegedly prescribed to “many” patients who didn’t actually have cancer. The DOJ also alleged that the former executives defrauded health insurers to approve payment of the drug for noncancer patients by receiving prior authorization directly from them and pharmacy benefit managers.